Why the study?
The study evaluated in vivo endothelial function and nitric oxide-dependent vasodilatation before and after cessation of long-term fourth-generation oral contraceptive pill use in a young, healthy premenopausal woman.
Does cessation of long-term fourth-generation oral contraceptive pill use improve microvascular endothelial function in a young, healthy woman?
Does cessation of long-term fourth-generation oral contraceptive pill use improve microvascular endothelial function in a young, healthy woman?
Cessation of long-term fourth-generation oral contraceptive pill use may substantially improve cutaneous microvascular endothelial function, independent of nitric oxide bioavailability.
The purpose of this case report was to evaluate in vivo endothelial function and nitric oxide (NO)‐dependent vasodilatation before and after the cessation of long‐term (11–12 years) fourth‐generation oral contraceptive pill (OCP) use in one young, healthy and premenopausal woman. This retrospective analysis includes data from six experimental visits: three visits during months 133–144 of fourth‐generation OCP use and three visits 19–22 months after OCP cessation. Endothelium‐dependent and NO‐dependent vasodilatation were assessed in the cutaneous microvasculature using laser‐Doppler flowmetry, a rapid local heating protocol (39°C, 0.1°C/s) and pharmacological perfusion through intradermal microdialysis fibres. The participant had consistent medical history and lifestyle behaviours throughout both hormonal exposures. Data are presented as the mean (SD). Endothelium‐dependent vasodilatation was 42 (10)% of site‐specific maximal cutaneous vascular conductance (CVC max ) during OCP use and 63 (10)%CVC max after OCP cessation (49% increase). Nitric oxide‐dependent vasodilatation was 70 (5)% contribution of NO during OCP use and 60 (15)%NO after OCP cessation (15% reduction). Baseline blood flow was greater after OCP cessation, but maximal blood flow was reduced. Data from this case report support a substantial increase in cutaneous microvascular endothelial function assessed via local heating after cessation of long‐term use of a fourth‐generation OCP, which does not appear to be attributable to increased NO bioavailability. Overall, these data suggest an improvement in endothelial and microvascular function after the cessation of long‐term use of a fourth‐generation OCP.
No takes yet. Share an insight, caveat, or question.
Turner et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: